Closed-Loop Medical Devices Might Reduce Iatrogenic Loss of Autonomous Action Selection

2017 ◽  
Vol 26 (4) ◽  
pp. 688-690
Author(s):  
OMAR F.F. ODISH ◽  
MARTIJN BEUDEL
Author(s):  
Zhihao Jiang ◽  
Miroslav Pajic ◽  
Rajeev Alur ◽  
Rahul Mangharam

PLoS ONE ◽  
2021 ◽  
Vol 16 (4) ◽  
pp. e0251001
Author(s):  
Ramin Bighamian ◽  
Jin-Oh Hahn ◽  
George Kramer ◽  
Christopher Scully

Physiological closed-loop controlled (PCLC) medical devices are complex systems integrating one or more medical devices with a patient’s physiology through closed-loop control algorithms; introducing many failure modes and parameters that impact performance. These control algorithms should be tested through safety and efficacy trials to compare their performance to the standard of care and determine whether there is sufficient evidence of safety for their use in real care setting. With this aim, credible mathematical models have been constructed and used throughout the development and evaluation phases of a PCLC medical device to support the engineering design and improve safety aspects. Uncertainties about the fidelity of these models and ambiguities about the choice of measures for modeling performance need to be addressed before a reliable PCLC evaluation can be achieved. This research develops tools for evaluating the accuracy of physiological models and establishes fundamental measures for predictive capability assessment across different physiological models. As a case study, we built a refined physiological model of blood volume (BV) response by expanding an original model we developed in our prior work. Using experimental data collected from 16 sheep undergoing hemorrhage and fluid resuscitation, first, we compared the calibration performance of the two candidate physiological models, i.e., original and refined, using root-mean-squared error (RMSE), Akiake information criterion (AIC), and a new multi-dimensional approach utilizing normalized features extracted from the fitting error. Compared to the original model, the refined model demonstrated a significant improvement in calibration performance in terms of RMSE (9%, P = 0.03) and multi-dimensional measure (48%, P = 0.02), while a comparable AIC between the two models verified that the enhanced calibration performance in the refined model is not due to data over-fitting. Second, we compared the physiological predictive capability of the two models under three different scenarios: prediction of subject-specific steady-state BV response, subject-specific transient BV response to hemorrhage perturbation, and leave-one-out inter-subject BV response. Results indicated enhanced accuracy and predictive capability for the refined physiological model with significantly larger proportion of measurements that were within the prediction envelope in the transient and leave-one-out prediction scenarios (P < 0.02). All together, this study helps to identify and merge new methods for credibility assessment and physiological model selection, leading to a more efficient process for PCLC medical device evaluation.


2016 ◽  
Vol 25 (4) ◽  
pp. 623-633 ◽  
Author(s):  
PHILIPP KELLMEYER ◽  
THOMAS COCHRANE ◽  
OLIVER MÜLLER ◽  
CHRISTINE MITCHELL ◽  
TONIO BALL ◽  
...  

Abstract:Closed-loop medical devices such as brain-computer interfaces are an emerging and rapidly advancing neurotechnology. The target patients for brain-computer interfaces (BCIs) are often severely paralyzed, and thus particularly vulnerable in terms of personal autonomy, decisionmaking capacity, and agency. Here we analyze the effects of closed-loop medical devices on the autonomy and accountability of both persons (as patients or research participants) and neurotechnological closed-loop medical systems. We show that although BCIs can strengthen patient autonomy by preserving or restoring communicative abilities and/or motor control, closed-loop devices may also create challenges for moral and legal accountability. We advocate the development of a comprehensive ethical and legal framework to address the challenges of emerging closed-loop neurotechnologies like BCIs and stress the centrality of informed consent and refusal as a means to foster accountability. We propose the creation of an international neuroethics task force with members from medical neuroscience, neuroengineering, computer science, medical law, and medical ethics, as well as representatives of patient advocacy groups and the public.


2017 ◽  
Vol 40 (6) ◽  
pp. 272-281
Author(s):  
Alen Karabegovic ◽  
Markus Hinteregger ◽  
Christoph Janeczek ◽  
Werner Mohl ◽  
Margit Gföhler

Background Currently available, pneumatic-based medical devices are operated using closed-loop pulsatile or open continuous systems. Medical devices utilizing gases with a low atomic number in a continuous closed loop stream have not been documented to date. This work presents the construction of a portable helium circulation addressing the need for actuating a novel, pneumatically operated catheter pump. The design of its control system puts emphasis on the performance, safety and low running cost of the catheter pump. Methods and results Static and dynamic characteristics of individual elements in the circulation are analyzed to ensure a proper operation of the system. The pneumatic circulation maximizes the working range of the drive unit inside the catheter pump while reducing the total size and noise production. Separate flow and pressure controllers position the turbine's working point into the stable region of the pressure creation element. A subsystem for rapid gas evacuation significantly decreases the duration of helium removal after a leak, reaching subatmospheric pressure in the intracorporeal catheter within several milliseconds. Conclusions The system presented in the study offers an easy control of helium mass flow while ensuring stable behavior of its internal components.


2018 ◽  
Vol 126 (6) ◽  
pp. 1916-1925 ◽  
Author(s):  
Bahram Parvinian ◽  
Christopher Scully ◽  
Hanniebey Wiyor ◽  
Allison Kumar ◽  
Sandy Weininger

2021 ◽  
Vol 24 (3) ◽  
pp. 20-25
Author(s):  
Raffaele Guida ◽  
Neil Dave ◽  
Francesco Restuccia ◽  
Emrecan Demirors ◽  
Tommaso Melodia

The promise of real-time detection and response to life-crippling diseases brought by the Implantable Internet of Medical Things (IIoMT) has recently spurred substantial advances in implantable technologies. Yet, existing medical devices do not provide at once the miniaturized end-to-end body monitoring, wireless communication and remote powering capabilities to implement IIoMT applications. This paper fills the existing research gap by presenting U-Verse, the first FDA-compliant rechargeable IIoMT platform packing sensing, computation, communication, and recharging circuits into a penny-scale platform. Extensive experimental evaluation indicates that U-Verse (i) can be wirelessly recharged and can store energy several orders of magnitude more than state-of-theart capacity in tens of minutes; (ii) with one single charge, it can operate from few hours to several days. Finally, U-Verse is demonstrated through (i) a closed-loop application that sends data via ultrasounds through real porcine meat; and (ii) a real-time reconfigurable pacemaker.


2015 ◽  
Vol 1 (1) ◽  
pp. 176-179
Author(s):  
Max Rockstroh ◽  
Stefan Franke ◽  
Thomas Neumuth

AbstractIn recent years, approaches for information and control integration in the digital operating room have emerged. A major step towards an intelligent operating room and a cooperative technical environment would be autonomous adaptation of medical devices and systems to the surgical workflow. The OR staff should be freed from information seeking and maintenance tasks. We propose a closed-loop concept integrating workflow monitoring, processing and (semi-)automatic interaction to bridge the gap between OR integration of medical devices and workflow-related information management.Four steps were identified for the implementation of workflow-driven assistance functionalities. The processing steps in the closed loop of workflow-driven assistance could either be implemented with centralized responsible components or in a cooperative agent-based approach. However, both strategies require a common framework and terminology to ensure interoperability between the components, the medical devices (actors) and the OR infrastructure.


Sign in / Sign up

Export Citation Format

Share Document